platinum
Showing 1 - 11 of 11
Small Cell Lung Cancer Trial in Spain (BMS-986012, Cisplatin, Etoposide)
Active, not recruiting
- Small Cell Lung Cancer
- BMS-986012
- +4 more
-
Barcelona, Spain
- +3 more
Apr 25, 2022
Esophageal Tumors, Esophageal Diseases, Digestive System Tumors Trial (Camrelizumab, Paclitaxel, Platinum)
Not yet recruiting
- Esophageal Neoplasms
- +2 more
- Camrelizumab
- +3 more
- (no location specified)
Nov 20, 2022
Lung Tumors Trial in Guangzhou (Sintilimab, Pemetrexed, Platinum)
Active, not recruiting
- Lung Neoplasms
- Sintilimab
- +3 more
-
Guangzhou, ChinaSun Yat-Sen University Cancer Center
Jan 27, 2021
Small Cell Lung Carcinoma Trial in Beijing (Camrelizumab,an engineered anti-PD-1 antibody, Platinum, Irinotecan)
Recruiting
- Small Cell Lung Carcinoma
- Camrelizumab,an engineered anti-PD-1 antibody
- +3 more
-
Beijing, ChinaBeijing Union Medical College Hospital
Jun 28, 2020
Hypopharyngeal Cancer Trial in Guangzhou (Docetaxel, 5-fluorouracil, Cisplatin)
Recruiting
- Hypopharyngeal Cancer
- Docetaxel
- +4 more
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital of Sun Yat-sen University
Aug 4, 2020
Breast Tumors Trial in Urumchi (EndostarTM Injection, Gemcitabine, Navelbine)
Unknown status
- Breast Neoplasms
- EndostarTM Injection
- +4 more
-
Urumchi, Xinjiang, ChinaThird Affiliated Hospital of Xinjiang Medical University
Jul 12, 2017
NSCLC Trial in Lodz (OCZ103-OS, Platinum, Gemcitabine)
Completed
- Non-small Cell Lung Cancer
- OCZ103-OS
- +2 more
-
Lodz, PolandEwa Kalinka-Warzocha
Oct 20, 2014
Non Small Cell Lung Cancer Trial in Rozzano (Gefitinib, Platinum)
Completed
- Non Small Cell Lung Cancer
- Gefitinib
- Platinum
-
Rozzano, Milan, ItalyFondazione Humanitas per la Ricerca
Apr 20, 2012